Current understanding of determinants for COVID-19-related cardiovascular and
thromboembolic (CVE) complications primarily covers clinical aspects with limited …

Epidemiological studies suggest that individuals with comorbid conditions including
diabetes, chronic lung, inflammatory and vascular disease, are at higher risk of adverse …

The risk of venous thromboembolism (VTE) is markedly increased in patients with COVID-19
(COVID-19 VTE) and is associated with higher COVID-19 mortality. 1 Whether the presence …

Venous thromboembolism occurs in up to one-third of patients with COVID-19. Venous
thromboembolism and COVID-19 may share a common genetic architecture, which has not …

ABSTRACT BACKGROUND Epidemiological studies indicate that as many as 20% of
individuals who test positive for COVID-19 develop severe symptoms that can require …

Understanding the genetic risk and mechanisms through which SARS-CoV-2 infection
outcomes and comorbidities interact to impact acute and long-term sequelae is essential if …

With the continued spread of COVID‐19 globally, it is crucial to identify the potential risk or
protective factors associated with COVID‐19. Here, we performed genetic correlation …

Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …

Background There is considerable variability in COVID-19 outcomes among younger adults,
and some of this variation may be due to genetic predisposition. Methods We combined …

Background COVID-19 manifests with huge heterogeneity in susceptibility and severity
outcomes. UK Black Asian and Minority Ethnic (BAME) groups have demonstrated …